A Subset of Non-Small Cell Lung Cancer Patients Treated with Pemetrexed Show <sup>18</sup>F-Fluorothymidine “Flare” on Positron Emission Tomography
Thymidylate synthase (TS) remains a major target for cancer therapy. TS inhibition elicits increases in DNA salvage pathway activity, detected as a transient compensatory “flare” in 3′-deoxy-3′-[<sup>18</sup>F]fluorothymidine positron emission tomography (<sup>18</sup>F-FLT P...
Main Authors: | Preetha Aravind, Sanjay Popat, Tara D. Barwick, Neil Soneji, Mark Lythgoe, Katherina B. Sreter, Jingky P. Lozano-Kuehne, Mattias Bergqvist, Neva Patel, Eric O. Aboagye, Laura M. Kenny |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/14/3718 |
Similar Items
-
Glucose–Thymidine Ratio as a Metabolism Index Using <sup>18</sup>F-FDG and <sup>18</sup>F-FLT PET Uptake as a Potential Imaging Biomarker for Evaluating Immune Checkpoint Inhibitor Therapy
by: Sera Oh, et al.
Published: (2022-08-01) -
Early Response Assessment to Targeted Therapy Using 3′-deoxy-3′[(18)F]-Fluorothymidine (<sup>18</sup>F-FLT) PET/CT in Lung Cancer
by: Kalevi Kairemo, et al.
Published: (2020-01-01) -
Comparison of <sup>18</sup>F-fluorothymidine Positron Emission Tomography/Computed Tomography and <sup>18</sup>F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Breast Cancer
by: Mio Mori, et al.
Published: (2022-10-01) -
Molecular Imaging with 3′-deoxy-3′[(18)F]-Fluorothymidine (<sup>18</sup>F-FLT) PET/CT for Early Response to Targeted Therapies in Sarcomas: A Pilot Study
by: Kalevi Kairemo, et al.
Published: (2020-02-01) -
Glutamate-Evoked Ca<sup>2+</sup> Responses in the Rat Suprachiasmatic Nucleus: Involvement of Na<sup>+</sup>/K<sup>+</sup>-ATPase and Na<sup>+</sup>/Ca<sup>2+</sup>-Exchanger
by: Pi-Cheng Cheng, et al.
Published: (2023-03-01)